Securities Class Action

In Litigation

0

Settlement

1

Closed

0

Total Settlement

$13.73M

Material Events

Critical Governance & Disclosure

2

Board, Voting & Shareholder Rights

4

Capital Structure & Financial Risk

1

Disclosure & Communications

6

SEC Filings

8-K

Current report

2026-11-17

View 8-K Current report on SEC.gov
Form 4

Statement of changes in beneficial ownership of securities

2026-10-20

View Form 4 Statement of changes in beneficial ownership of securities on SEC.gov
8-K

Current report

2026-10-19

View 8-K Current report on SEC.gov
DEFA14A

Additional definitive proxy soliciting materials and Rule 14(a)(12) material

2026-10-19

View DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material on SEC.gov
DEF 14A

Other definitive proxy statements

2026-09-28

View DEF 14A Other definitive proxy statements on SEC.gov

Insider Transaction

No Insider Transactions found for CytoDyn Inc.